These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3245169)

  • 21. [The liver-protective properties of D-glucosamine].
    Sal'nikova SI; Drogovoz SM; Zupanets IA
    Farmakol Toksikol; 1990; 53(4):33-5. PubMed ID: 2226756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Superoxide dismutase--a prospective hepatoprotective agent].
    Drogovoz SM; Slyshkov VV; Sarbash TF; Sal'nikova SI; Derimedved' LV; Sharonov BP
    Eksp Klin Farmakol; 1993; 56(4):51-2. PubMed ID: 8220019
    [No Abstract]   [Full Text] [Related]  

  • 23. [The efficacy of hydroxycinnamic acids in toxic lesions of the liver].
    Drogovoz SM; Slyshkov VV; Sal'nikova SI
    Eksp Klin Farmakol; 1993; 56(2):55-8. PubMed ID: 8348042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of antioxidants in a combined carbon tetrachloride and ethanol lesion of the liver].
    Skakun NP; Koval'chuk SF
    Farmakol Toksikol; 1987; 50(3):97-9. PubMed ID: 3609289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Liver-protective action of silybinine in experimental CCl4 poisoning].
    Vengerovskiĭ AI; Chuchalin VS; Morokova EA; Prishchep TP; Saratikov AS
    Farmakol Toksikol; 1987; 50(5):67-9. PubMed ID: 3691784
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of avicularine on the cholagogic function of the liver].
    Bezruk PI
    Farmakol Toksikol; 1969; 32(5):574-5. PubMed ID: 5364672
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antioxidant regulation of the changes in liver excretory function in toxic hepatitis].
    Vinogradova LF; Mirzoian ZhA
    Eksp Klin Farmakol; 1993; 56(5):50-2. PubMed ID: 8312814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Controlled clinical evaluation of cicloxilic acid in hepatopathies caused by psychopharmacological agents].
    Bocci U; Beretta G
    Clin Ter; 1980 May; 93(4):373-88. PubMed ID: 6998639
    [No Abstract]   [Full Text] [Related]  

  • 29. [Excretory function of the liver with an allyl alcohol lesion and the antioxidant correction of the disorders].
    Skakun NP; Moroz GS; Tsiliurik IT; Volkova LA; Oleĭnik AV
    Farmakol Toksikol; 1987; 50(1):100-3. PubMed ID: 3556542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Choleretic and cholagogic medication, its therapeutic action].
    Bucurescu A
    Munca Sanit; 1971 Sep; 19(9):549-56. PubMed ID: 5211445
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ultrastructural changes in the rat liver under the effect of various choleretics].
    Hegewald G; Bärenwald G; Möritz KU; Grisk A
    Acta Hepatosplenol; 1968; 15(6):382-9. PubMed ID: 5710490
    [No Abstract]   [Full Text] [Related]  

  • 32. [Electron micro- scopic findings in liver damage due to drugs (choleretics, cyclophosphamide, phenylindandion)].
    Hegewald G; Bärenwald G; Grisk A; Möritz KU
    Z Gesamte Inn Med; 1968 Dec; 23(24):821-4. PubMed ID: 5710624
    [No Abstract]   [Full Text] [Related]  

  • 33. [Substance-induced liver injury as a model for evaluating hepatoprotective drugs].
    Trcka V; Siblíková O
    Cas Lek Cesk; 1985 Feb; 124(6):161-4. PubMed ID: 3971402
    [No Abstract]   [Full Text] [Related]  

  • 34. [The choleretics].
    Geoffroy H; Dezoteux H
    Maroc Med; 1967 Jul; 47(504):506-11. PubMed ID: 5613355
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of tests of the hepatoprotective effect of silymarin in experimental animals].
    Siblíková O; Trcka V; Vakocová H; Tichý M
    Cas Lek Cesk; 1985 Feb; 124(6):165-9. PubMed ID: 3971403
    [No Abstract]   [Full Text] [Related]  

  • 36. [Silymarin, a membranotropic drug: clinical and experimental observations].
    De Martiis M; Fontana M; Sebastiani F; Parenzi A
    Clin Ter; 1977 May; 81(4):333-62. PubMed ID: 880785
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cholagogic agents].
    Pasichnyk IKh
    Farm Zh; 1978; (2):39-43. PubMed ID: 658339
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mechanisms of hepatoprotective action of new nicotinic acid derivatives in experimental CCL4-induced liver injury].
    Strechen' SB; Kresiun VI
    Biull Eksp Biol Med; 1992 Jul; 114(7):58-61. PubMed ID: 1421311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepato-biliary effects of rifampicin in rats].
    Rozé C; Camilleri JP; Vaille C; Souchard M; Debray C
    Med Chir Dig; 1976 May; 5(6):373-7. PubMed ID: 1011900
    [No Abstract]   [Full Text] [Related]  

  • 40. [The pharmacodynamics of hepatic protectors from the lady's-thistle (Silybum marianum)].
    Rumiantseva ZhN
    Vrach Delo; 1991 May; (5):15-9. PubMed ID: 1866906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.